SAN FRANCISCO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- PACS Group, Inc. (NYSE: PACS) experienced a significant decline in its share price on November 4, 2024, following the publication of an explosive short report by activist short seller Hindenburg Research. The report, titled “PACS Group: How To Become A Billionaire In The Skilled Nursing Industry By Systematically Scamming Taxpayers,” accused the company of engaging in fraudulent practices. Hagens Berman has begun an investigation into the matter and urges inv ...

SAN DIEGO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Dicello Levitt LLP announces that it has launched an investigation into whether PACS Group, Inc. (“PACS” or the “Company”) (NYSE: PACS) complied with federal securities laws. The Firm’s investigation focuses on whether the Company violated the federal securities laws, issued false and/or misleading statements, and/or failed to disclose information required to be disclosed to investors. Investors who purchase PACS securities and those with information about the al ...

NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into PACS Group, Inc. (NYSE: PACS) for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/pacs-group-inc. Why Did PACS’s Stock Drop? PACS is one of the largest operators of skilled nursing facilities in the United States. PACS has repeatedly represen ...

NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of purchasers of PACS Group, Inc. (“PACS”) common stock (NYSE: PACS). PACS operates skilled nursing and assisted living facilities. PACS had its IPO April 10, 2024 and sold 24.6 million shares at $21.00 per share. On September 5, 2024, PACS and its two co-founders sold 19.0 million shares at $36.25 per share in a secondary equity offering. During the trading day on November 4, 2024, Hindenburg Research is ...

文章核心观点 - PACS Group公司涉嫌通过滥用2020年至2023年期间的COVID-19豁免权,不当膨胀了Medicare收入 [2] - 这可能会给公司带来重大的监管风险 [2] 公司概况 - PACS Group是一家上市公司,股票代码为NYSE: PACS [1] - 公司股价在一天内下跌超过30% [2] 调查情况 - 律师事务所Block & Leviton正在调查PACS Group是否存在证券法违规行为 [1][4] - 投资者如果在PACS Group的投资中亏损,可以联系该律师事务所了解如何挽回损失 [1][3][5] - 如果有内部消息人士,可以考虑协助调查或通过SEC举报,有机会获得最高30%的奖励 [6] - Block & Leviton是一家著名的证券集体诉讼律所,曾为投资者挽回巨额损失 [7]

PACS Group, Inc. Reports Second Quarter 2024 Results August 12, 2024 Conference Call and Webcast scheduled for today, August 12, 2024, at 5:00 pm ET. FARMINGTON, Utah—(BUSINESS WIRE)—PACS Group, Inc. (NYSE: PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the second quarter of 2024. Highlights: • GAAP net income (loss) was $38.2 million for the six months ended June 30, 2024 and $ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to ______. Commission file number 001-42011 _________________________ PACS Group, Inc. (Exact name of ...

PACS Group, Inc. Reports First Quarter 2024 Results 05/13/2024 Conference Call and Webcast scheduled for tomorrow, May 14, 2024, at 4:00 pm ET. FARMINGTON, Utah—(BUSINESS WIRE)—PACS Group, Inc. (NYSE: PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the first quarter of 2024, reporting net income of $49.1 million, Adjusted EBITDA of $88.5 million and Adjusted EBITDAR of $152.5 mil ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to ______. Commission file number 001-42011 _________________________ PACS Group, ...